DCM
RCEL icon

Driehaus Capital Management’s Avita Medical RCEL Stock Holding History

Driehaus Capital Management’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-209,257
Closed -$2.87M – 437
2023
Q4 		$2.87M Sell
209,257
-286,511
-58% -$3.28M 0.03% 286
2023
Q3 		$7.24M Buy
+495,768
New +$8.39M 0.09% 247
2021
Q3 		– Sell
-130,000
Closed -$2.67M – 463
2021
Q2 		$2.67M Hold
130,000
– – 0.04% 303
2021
Q1 		$2.58M Buy
+130,000
New +$3.02M 0.04% 314

Other funds holding RCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Driehaus Capital Management's RCEL Position: Q1 2024 in Review

Driehaus Capital Management sold out of Avita Medical (RCEL) in Q1 2024, closing a stake of 209,257 shares — an estimated $2.87M sold.

Driehaus Capital Management first reported a position in RCEL in Q1 2021 and held it in 4 quarters. The position peaked at $7.24M in Q3 2023. 82 funds tracked by Wall St. Rank hold RCEL as of Q1 2024.

  • Driehaus Capital Management reported no remaining Avita Medical position as of Q1 2024 after selling out during the quarter.
  • Driehaus Capital Management sold 209,257 Avita Medical shares in Q1 2024, an estimated $2.87M.
  • Driehaus Capital Management first reported a position in Avita Medical in Q1 2021 and held it in 4 quarters.
  • Driehaus Capital Management's Avita Medical position peaked at $7.24M in Q3 2023.
  • 82 funds tracked by Wall St. Rank held Avita Medical as of Q1 2024.

Based on Driehaus Capital Management's 13F filing for Q1 2024, filed 15 May 2024.